Roche Diagnostics International Ltd - Company Profile
Powered by 
All the data and insights you need on Roche Diagnostics International Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Roche Diagnostics International Ltd Strategy Report
- Understand Roche Diagnostics International Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a provider of diagnostic system solutions to clinics, laboratories and doctors’ offices. The company develops, produces and services instruments and software systems used in in-vitro diagnostics and bioanalytical research. It also offers diagnostic analysis systems and workflow solutions, and molecular diagnostic reagents and test systems. Its major products include point-of-care testing devices and blood glucose meters. The company offers products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers, and pharmacists. It has operations in the Americas, Africa, the Middle East and Europe, among others. Roche Diagnostics is headquartered in Rotkreuz, Switzerland.
Headquarters
Switzerland
Address
Forrenstrasse 2, Rotkreuz, Zug, 6343
Website
www.roche.ch
Telephone
41 41 7992244
No of Employees
2,600
Industry
Medical Equipment
Revenue (2022)
$18.6B
Roche Diagnostics International Ltd premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Centralized and Point of Care Solutions: | Diagnostics |
| Serum Work Area (SWA): immunoassays and clinical chemistry | |
| Point-of-Care (POC) Testing | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In January, the company signed a collaboration agreement with Jana Care to launch and distribute its blood testing platform. |
| 2022 | Plans/Strategy | In October, the company announced its plans to introduce its three next-generation SARS-CoV-2 rapid antigen tests for self-test and professional. |
| 2021 | Contracts/Agreements | In December, the company and Shanghai Pharmaceutical Kangdele entered into a strategic collaboration to create excellent supply chain services. |
Competitor Comparison
| Key Parameters | Roche Diagnostics International Ltd | Danaher Corp | Siemens Healthineers AG | Becton Dickinson and Co | bioMerieux SA |
|---|---|---|---|---|---|
| Headquarters | Switzerland | United States of America | Germany | United States of America | France |
| City | Rotkreuz | Washington | Forchheim | Franklin Lakes | Craponne |
| State/Province | Zug | WashingtonD.C. | - | New Jersey | Rhone Alpes |
| No. of Employees | 2,600 | 61,000 | 71,400 | 73,000 | 14,651 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Thomas Schinecker | Chief Executive Officer | Senior Management | 2019 | - |
| Tim Niskanen | General Manager - Roche Diagnostics Switzerland | Senior Management | 2020 | - |
| Andrew Klopp | General Manager - Roche Diagnostics International | Senior Management | 2020 | - |
| Narendra Varde | Managing Director - India and Neighbouring Markets, Roche Diagnostics India | Senior Management | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward